Contact this trialFirst, we need to learn more about you.
Anti-viral agent
Amantadine for Traumatic Brain Injury
Recruiting0 awardsPhase 2
Portland, Maine
"This trial aims to determine if the treatment is safe and well-tolerated. Patients will be given either the MR-301 drug or a placebo and their outcomes will be compared, including neurological responses,
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service